Tirzepatide getting a twin GLP-one and GIP agonist, it is suggested that the GIP component of dual agonism could possibly be liable for the additional gain, offered the likely advantage of GIP receptor agonism on peripheral insulin sensitization. As a result, tirzepatide was more practical than dulaglutide in minimizing fasting dietary TAG [6,seve